US equities |
GOOGL $324.89 ▲+0.00% GOOG $321.89 ▲+0.00% MU $983.23 ▲+0.00% SNDK $1,404.77 ▲+0.00% SKHY $164.70 ▲+0.00% LITE $913.95 ▲+0.00% MSFT $531.01 ▲+0.00% INTC $95.53 ▲+0.00%
FinancialContent

KORU Medical Systems, Inc. - Common Stock (NQ:KRMD)

3.220 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about KORU Medical Systems, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU (KRMD) Q2 2026 Earnings Call Transcript ↗
Record quarterly revenue and first profitable quarter since 2019 signal momentum. 
Via The Motley Fool
Topics Earnings Supply Chain
News headline image
KORU Medical Systems Q2 Earnings Call Highlights ↗
KORU Medical Systems (NASDAQ:KRMD) reported second-quarter revenue of $12 million, up 18% from a year earlier, as domestic patient starts, market-share gains and international demand supported growth.... 
Via MarketBeat
Topics Earnings
Koru Medical Systems (NASDAQ:KRMD) Slips on Full-Year Revenue Guidance Cut and U.S. Oncology Strategic Pivot ↗
Via Chartmill
KORU Medical Systems (NASDAQ:KRMD) Soars 16% After Q1 Earnings Beat ↗
Via Chartmill
KORU Medical Systems Inc (NASDAQ:KRMD) Shows Minervini Trend Template and Growth Momentum Alignment ↗
Via Chartmill
News headline image
Earnings Scheduled For November 12, 2025 ↗
 
Via Benzinga
News headline image
KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
Kaskela Law LLC Announces Investigation of KORU Medical Systems, Inc. (KRMD) and Encourages Long-Term KRMD Shareholders to Contact the Firm
From Kaskela Law LLC
Via Business Wire
News headline image
KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
Koru Medical (KRMD) Q1 2026 Earnings Transcript ↗
Koru Medical (KRMD) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
KORU Medical Systems Announces First Quarter 2026 Results
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026
From KORU Medical Systems Inc.
Via Business Wire
News headline image
KORU Medical (KRMD) Q4 2025 Earnings Transcript ↗
KORU Medical (KRMD) Q4 2025 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Announces CEO Transition
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems to Participate in Upcoming Investor Conferences
From KORU Medical Systems
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems
From KORU Medical Systems, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >